Table 4.
Hepatic antioxidant and oxidation product data of the rats (data are means ± SD of 6 individuals/group) (GSH: reduced glutathione, GSHPx: glutathione peroxidase, CD: conjugated dienes, CT: conjugated trienes, MDA: malondialdehyde).
Liver | Days in Treatment | Control | 20 ppm | 50 ppm | 100 ppm |
---|---|---|---|---|---|
GSH (micromol/g) | 5 | 2.72 ± 0.76 | 3.01 ± 0.41 | 3.06 ± 0.71 | 2.95 ± 1.15 |
10 | 3.2 ± 0.27 | 4.12 ± 1.19 | 3.52 ± 1 | 3.98 ± 1.14 | |
GSHPx (IU/g prot.) | 5 | 1.39 ± 0.31 ab | 1.11 ± 0.1 a | 1.82 ± 0.42 b | 1.6 ± 0.36 ab |
10 | 1.42 ± 0.2 | 2.01 ± 1.02 | 1.05 ± 0.53 | 1.61 ± 1.06 | |
MDA (nmol/g) | 5 | 55.6 ± 3.19 a | 69.9 ± 4.09 b | 64.9 ± 7.57ab | 68.9 ± 8.52 b |
10 | 47.3 ± 14.2 a | 74.7 ± 12.4 b | 61.5 ± 13.2ab | 63.6 ± 3.94 ab | |
CD (Abs. 232 nm) | 5 | 0.57 ± 0.02 | 0.58 ± 0.03 | 0.59 ± 0.02 | 0.56 ± 0.04 |
10 | 0.6 ± 0.03 | 0.62 ± 0.02 | 0.63 ± 0.04 | 0.64 ± 0.12 | |
CT (Abs. 268 nm) | 5 | 0.22 ± 0.01 | 0.21 ± 0.01 | 0.22 ± 0.01 | 0.21 ± 0.01 |
10 | 0.22 ± 0.01 | 0.23 ± 0.01 | 0.24 ± 0.01 | 0.25 ± 0.07 |
a, b: small uppercase letters indicate significant difference (p < 0.05) between means of one row. Bold number pairs indicate significant difference (p < 0.05) between 5- and 10-day treatment data.